Internal Medicine 1517 - Internal Medicine Alert - Sep 15, 2011

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/11. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Joseph E. Scherger, MD, MPH
Clinical Professor, University of California, San Diego

Allan J. Wilke, MD
Professor, Department of Introduction to Clinical Medicine,
Ross University School of Medicine,
Commonwealth of Dominica

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor, Assistant Director
Family Practice Residency
Program, University of Florida

Authors
Michael H. Crawford, MD
Professor of Medicine
University of California, San Francisco;
Lucie Stern Chair in Cardiology
Chief of Clinical Cardiology
University of California
San Francisco Medical Center

Peer reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • A Placebo the Patient Believes in is Effective for the Common Cold
  • Secondary Prevention of Postherpetic Neuralgia
  • Aspirin for Primary Prevention
  • Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Tablets (Complera™)
  • Clinical Briefs
  • Is the AV Block Complete?

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Amylin, Boehringer Ingelheim, Novo Nordisk, and Symbiotix; he serves on the speakers bureau of Boehringer Ingelheim, Novo Nordisk, and Teva. Associate editors Joseph E. Scherger, MD, MPH, Allan J. Wilke, MD, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, author Michael H. Crawford, MD, and peer reviewer Gerald Roberts, MD report no financial relationship to this field of study. Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda. Ken Grauer, MD is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

Copyright 2011 AHC Media. All rights reserved.